(HealthDay)—Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.
Dec 4, 2017
0
0
Not every drug designed by pharmaceutical companies makes it to the market; very few do. Only 9.6% of new drugs in development in the years 2006-2015 successfully made it to the market to be used by patients. That's because ...
Oct 11, 2017
0
4
China said Monday it would ban a designer drug called U-47700 and three others, following U.S. pressure to do more to control synthetic opioids blamed for fast-rising overdose deaths in the United States.
Jun 19, 2017
0
0
Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected, sometimes life-threatening side effects or complications, a new analysis found.
May 9, 2017
1
127
U.S. regulators have approved a new drug that harnesses the immune system to treat advanced bladder cancer.
May 1, 2017
0
2
The inauguration of a new United States president is heralded as a peaceful transition of power. However, when a new administration actually takes office, the fast change in healthcare policy direction and ideological political ...
Mar 2, 2017
0
4
Last year, the Food and Drug Administration approved just 22 new therapeutic drugs, which is less than half the number approved in 2015. The cover story in Chemical & Engineering News (C&EN), the weekly newsmagazine of the ...
Feb 1, 2017
0
0
The Trump administration says it is pulling back advertising to promote HealthCare.gov as open enrollment draws to a close for this year.
Jan 27, 2017
0
0
The nation's homeless are proving to be especially susceptible to a new, dirt-cheap version of synthetic marijuana, which leaves users glassy-eyed, aimless, sprawled on streets and sidewalks oblivious to their surroundings ...
Dec 17, 2016
0
1
Although new drugs must be shown to be both safe and effective for approval by the Food and Drug Administration, sick newborns receive most of their drug treatment off-label and without the evidence provided for adults and ...
Oct 4, 2016
0
0
